Related references
Note: Only part of the references are listed.Changes in bone mineral density over 10 years in patients with early rheumatoid arthritis
Lisa Theander et al.
RMD OPEN (2020)
Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide
Hennie G. Raterman et al.
DRUGS & AGING (2019)
Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort
Ingiald Hafstrom et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Association of High Anti-Cyclic Citrullinated Peptide Seropositivity and Lean Mass Index With Low Bone Mineral Density in Rheumatoid Arthritis
Katherine D. Wysham et al.
ARTHRITIS CARE & RESEARCH (2018)
Inflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia
R. M. ten Brinck et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes
Emma C. de Moel et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis
Anca I. Catrina et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients
Irene Llorente et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients
Giovanni Orsolini et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss
Akilan Krishnamurthy et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study)
Lotte Heimans et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis
Serena Bugatti et al.
ARTHRITIS RESEARCH & THERAPY (2016)
HLA and anti-citrullinated protein antibodies: Building blocks in RA
Diane van der Woude et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2015)
Management of osteoporosis in rheumatoid arthritis patients
Jos N. Hoes et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate
Aase Haj Hensvold et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies
Arnd Kleyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis
Barbara Hauser et al.
RHEUMATOLOGY (2014)
Autocrine signaling is a key regulatory element during osteoclastogenesis
Paul Kopesky et al.
BIOLOGY OPEN (2014)
Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study)
Kirsten Wevers-de Boer et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Ulrike Harre et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Georg Schett et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Bone metabolism is altered in preclinical rheumatoid arthritis
Dirkjan van Schaardenburg et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis
M. Gueler-Yueksel et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
The role of DXA bone density scans in the diagnosis and treatment of osteoporosis
Glen M. Blake et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides
Merete Pedersen et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
AHM van der Helm-van Mil et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Share Paper
